Recovery Kinetics After Different Sprint Training Protocols (STRecovery) (STRecovery)

Recovery Kinetics After Different Sprint Training Protocols

Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Running speed improvement is one of the most basic components of a sprint and power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Sprinting is performed through the stretch-shortening cycle and highly includes the component of eccentric muscle contraction, which can lead to exercise induced muscle damage (EIMD). This phenomenon includes symptoms such as plasma CK elevation, delayed onset of muscle soreness, reduction in force production and a reduction in agility and speed. However, despite the fact that sprint training can cause EIMD symptoms and a performance reduction the following days, research evidence on the recovery kinetics after sprint training are scarce. However, such information is critical for coaches and athletes, in order to effectively design a training program and incorporate the training components in the training microcycle, to avoid injuries and maximize performance. The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

Study Overview

• Status: Completed
• Conditions: Sprint Training
• Intervention / Treatment: Other: Unresisted sprint training; Other: Resisted sprint training with load equal to 10% of body weight; Other: Resisted sprint training with load equal to 20% of body weight; Other: Control trial

Detailed Description

Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Thus, running speed improvement consists one of the most basic aims of a sprinter's and a power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Evidence suggests that resisted sprint training is more effective in improving acceleration compared to sprint training without additional load. Sprinting is performed through the stretch-shortening cycle, where the pre-activated muscle is first stretched (eccentric action) and then followed by the shortening (concentric) action. Thus, sprint training highly includes the component of eccentric contraction. However, eccentric muscle action, especially when unaccustomed, can lead to exercise-induced muscle damage (EIMD). Although concentric and isometric exercise may also lead to muscle injury, the amount of damage after eccentric muscle contractions is greater. EIMD, amongst others, is accompanied by increased levels of creatine kinase (CK) into the circulation, increased delayed onset of muscle soreness (DOMS), reduction of force production, reduction of agility and speed. Nevertheless, despite the fact that sprint training comprises eccentric muscle actions and consequently can lead to muscle injury and muscle performance reduction during the following days, the recovery kinetics after acute sprint training have not been adequately studied. However, such information is critical for both coaches and athletes to effectively design the training microcycles and incorporate the training components, as well as to reduce injury risk.

The aim of the present study is to examine the recovery kinetics of EIMD indices, muscle performance and neuromuscular fatigue, after different sprint training protocols.

According to a preliminary power analysis (a probability error of 0.05, and a statistical power of 80%), a sample size of 8 - 10 subjects per group was considered appropriate in order to detect statistically meaningful changes between groups.

The study will be performed in a randomized, cross over, repeated measures design. During the first 1st and 2nd visit, all participants will sign an informed consent form after they will be informed about all the benefits and risks of the study and they will fill in and sign a medical history questionnaire. Fasting blood samples will be collected in order to estimate muscle damage concentration markers. Participants will be instructed by a dietitian how to record a 7-days diet recalls to ensure that they do not consume to greater extent nutrients that may affect EIMD and fatigue (e.g. antioxidants, amino acids, etc.) and to ensure that the energy intake during the trials will be the same. Assessment of body mass and body height, body composition, and aerobic capacity (VO2max), will be performed. Running speed of 10 m, 20 m and 30 m sprint will be measured on a track and field stadium. Squat jump and countermovement jump will be performed on a force platform to assess jump height, ground reaction force, peak and mean power, vertical stiffness and peak rate of force development; at the same time, peak and mean normalized EMG during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and gluteus maximum muscles will be assessed. The peak concentric, eccentric and isometric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Maximal voluntary isometric contraction (MVIC) of the knee extensors at 65o in both limbs, as well as the fatigue rate during MVIC through the percent drop of peak torque between the first and the last three seconds of a 10-sec MVIC.

During the 3rd visit, participants will be randomly assigned into, and perform one of the four different conditions of the study design: a) unresisted sprint training, b) resisted sprint training with a load of 10% of body weight (BW), c) resisted sprint training with a load of 20% of BW d) control condition. Prior to each experimental protocol, assessment of DOMS in the knee flexors (KF) and extensors (KE) of both limbs, as well as blood lactate assessment will be performed. Additionally, DOMS of KF and KE, running speed at 10 m, 20 m and 30 m sprint, peak concentric, eccentric and isometric isokinetic torque, squat and countermovement jump height, as well as ground reaction force, peak and mean power, vertical stiffness and peak rate of force development during squat and countermovement jump, alongside with peak and mean normalized electromyography (EMG) during the concentric phase of the squat jump, and during eccentric and concentric phases of the counter movement jump, for the vastus lateralis, biceps femoris, gastrocnemius, and tibialis anterior muscles will be assessed immediately after, 24h, 48h and 72h after the end of the trial. MVIC of the knee extensors of both limbs, as well as the fatigue rate during MVIC will also be assessed at 1h, 2h and 3h, as well as 24h, 48h, and 72h after the end of the trial. Blood lactate will also be assessed at 4 min, while creatine kinase at 24h, 48h, and 72h after the end of the trial. The exact above procedures will be repeated by the participants during the remaining three experimental trials (7th - 10th, 11th - 13th, and 14th - 16th visits).

• Study Type: Interventional
• Enrollment (Actual): 10
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Greece
  • Thessaly
    • Trikala, Thessaly, Greece, 42100
      • Department of Physical Education and Sport Science

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Male

Description

Inclusion Criteria:

• Srinters or athletes that comprise sprint training in their training programs
• Absense of musculoskeletal injuries (≥ 6 months)
• Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
• Abstence from participation at exercise with eccentric component (≥ 3 days)
• Abstence from alcohol and energy drings consumption before each experimental trial

Exclusion Criteria:

• Musculoskeletal injuries (≤ 6 months)
• Use of ergogenic supplements or other drugs (≤ 1 month)
• Participation at exercise with eccentric component (≤ 3 days)
• Alcohol and energy drings consumption before the experimental trials

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Unresisted sprint training; Participants will perform an acute training bout of unresisted sprints.	Other: Unresisted sprint training; Particiapants will perform: 2 sets of 3 x 20m sprint 1 set of 3 x 30m sprint
Experimental: Resisted sprint training with load equal to 10% of body weight; Participants will perform an acute training bout of resisted sprints with load equal to 10% of body weight.	Other: Resisted sprint training with load equal to 10% of body weight; Particiapants will perform: 2 sets of 3 x 20m sprint 1 set of 3 x 30m sprint
Experimental: Resisted sprint training with load equal to 20% of body weight; Participants will perform an acute training bout of resisted sprints with load equal to 20% of body weight.	Other: Resisted sprint training with load equal to 20% of body weight; Particiapants will perform: 2 sets of 3 x 20m sprint 1 set of 3 x 30m sprint
Experimental: Control trial; Participants will perform no training protocol. They will only perform all the measurements.	Other: Control trial; Participants will not perform any sprint training protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in Creatine kinase	CK will be measured in plasma using a Clinical Chemistry Analyzer with commercially available kits.	Baseline (pre), post-, 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in DOMS	DOMS of knee extensors and knee flexors of both lower extremities will be measured during palpation of the muscle belly and the distal regionafter performing three repetitions of a full squat.	Baseline (pre), post-, 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in blood lactate	Lactate will be measured in capillary blood with a hand-portable analyzer.	Baseline (pre), 4 minutes post-trial
Changes in 10m sprint time	20m sprint time will be measured using light cells Chronojump system.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in 20m sprint time	20m sprint time will be measured using light cells Chronojump system.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in 30m sprint time	30m sprint time will be measured using light cells Chronojump system.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in squat jump height	Squat jump height will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in ground reaction force (GRF) during squat jump	GRF during squat jump will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak power during squat jump	Peak power during squat jump will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in mean power during squat jump	Mean power during squat jump will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in vertical stiffness during squat jump	Vertical stiffness during squat jump will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak rate of force development (RFD) during squat jump	RFD during squat jump will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak normalized EMG during squat jump test	Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and tibialis anterior muscles during the concentric phase of the squat jump.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in mean normalized EMG during squat jump test.	Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius, and tibialis anterior muscles during the concentric phase of the squat jump.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in countermovement jump height	Countermovement jump height will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in ground reaction force (GRF) during countermovement jump	GRF will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak power during countermovement jump	Peak power will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in mean power during countermovement jump	Mean power will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in vertical stiffness during countermovement jump	Vertical stiffnesswill be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak rate of force development (RFD) during countermovement jump	RFD will be measured on a dynamometer using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak normalized EMG during countermovement jump test	Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius and gluteus maximum muscles during the eccentric and concentric phases of the countermovement jump test.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in mean normalized EMG during countermovement jump test	Electromyography data will be collected wirelessly at 2000Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus lateralis, biceps femoris, gastrocnemius and gluteus maximum muscles during the eccentric and concentric phases of the countermovement jump test.	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak concentric torque	Concentric torque of knee extensors and knee flexors will be measured on an isokinetic dynamometer	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak eccentric torque	Concentric torque of knee extensors and knee flexors will be measured on an isokinetic dynamometer	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in peak isometric torque	Concentric torque of knee extensors and knee flexors will be measured on an isokinetic dynamometer	Baseline (pre), 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in maximal voluntary isometric contraction (MVIC)	MVIC of knee extensors will be measured on an isokinetic dynamometer	Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial
Changes in fatigue rate of maximal voluntary isometric contraction (MVIC)	Fatigue rate during MVIC will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-second maximal isometric contaction	Baseline (pre), 1 hour post-, 2 hours post-, 3 hours post-, 24 hours post-, 48 hours post-, 72 hours post-trial
Change in field activity during the sprint training protocols	Field activity will be continuously recorded during the sprint training protocols using global positioning system (GPS) technology	Throughout the sprint training protocols
Change in heart rate during the sprint training protocols	Heart rate will be continuously recorded during during the sprint training protocols using heart rate monitors	Throughout the sprint training protocols

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Body mass index (BMI)	BMI will be calculated from the ratio of body mass/ body height squared	Baseline
Maximal oxygen consumption (VO2max)	Maximal oxygen consumption will be measured by open circuit spirometry via breath by breath method	Baseline
Body fat	Body fat will be measured by using Dual-emission X-ray absorptiometry	Baseline
Lean body mass	Lean body mass will be measured by using Dual-emission X-ray absorptiometry	Baseline
Dietary intake	Dietary intake will be assessed using 7-day diet recalls	Baseline
Body weight	Body weight will be measured on a beam balance with stadiometer	Baseline
Body height	Body height will be measured on a beam balance with stadiometer	Baseline

Collaborators and Investigators

• Sponsor: University of Thessaly
• Investigators: Principal Investigator: Chariklia K Deli, PhD, Department of Physical Education and Sport Science, University of Thessaly

Publications and helpful links

General Publications

• Deli CK, Fatouros IG, Paschalis V, Georgakouli K, Zalavras A, Avloniti A, Koutedakis Y, Jamurtas AZ. A Comparison of Exercise-Induced Muscle Damage Following Maximal Eccentric Contractions in Men and Boys. Pediatr Exerc Sci. 2017 Aug;29(3):316-325. doi: 10.1123/pes.2016-0185. Epub 2017 Feb 6.
• Zafeiridis A, Saraslanidis P, Manou V, Ioakimidis P, Dipla K, Kellis S. The effects of resisted sled-pulling sprint training on acceleration and maximum speed performance. J Sports Med Phys Fitness. 2005 Sep;45(3):284-90.
• Bachero-Mena B, Gonzalez-Badillo JJ. Effects of resisted sprint training on acceleration with three different loads accounting for 5, 12.5, and 20% of body mass. J Strength Cond Res. 2014 Oct;28(10):2954-60. doi: 10.1519/JSC.0000000000000492.
• Baird MF, Graham SM, Baker JS, Bickerstaff GF. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab. 2012;2012:960363. doi: 10.1155/2012/960363. Epub 2012 Jan 11.
• Petrakos G, Morin JB, Egan B. Resisted Sled Sprint Training to Improve Sprint Performance: A Systematic Review. Sports Med. 2016 Mar;46(3):381-400. doi: 10.1007/s40279-015-0422-8.

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2021
• Primary Completion (Actual): November 30, 2021
• Study Completion (Actual): November 30, 2021

Study Registration Dates

• First Submitted: February 11, 2021
• First Submitted That Met QC Criteria: February 20, 2021
• First Posted (Actual): February 23, 2021

Study Record Updates

• Last Update Posted (Actual): February 18, 2022
• Last Update Submitted That Met QC Criteria: February 17, 2022
• Last Verified: February 1, 2022

More Information

Terms related to this study

• Keywords: recovery; neuromuscular fatigue; muscle performance; muscle damage; sprint training
• Other Study ID Numbers: Sprint training-Recovery Study

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No